On a day when Santa Claus delivered a truckload of coal to Wall Street, cannabis stocks experienced volatile measures amid continued uncertainty over the treatment of their products by the US government after the Farm Bill came into force last week had kicked.
Aphira (APHA), winner of the # 1 on the NYSE (+ 14.4%), cut trade by 14.4%.
Aurora cannabis (ACB) also gained 2.5%.
However, other players in space fell behind while the Canadian Tilray played (TLRY) off 4. 7%, DavidsTeas (DTEA) dropped 10% and New Age Beverages (NBEV) more than 13%.
The controversy over the legality of cannaboid releated products continues despite last week's farm bill that legalized hemp cultivation in the US.
A Declaration by FDA Commissioner Scott Gottlieb on December 20 reaffirmed the agency's power to regulate and control products containing cannabis or compounds derived from cannabis under the Federal Food, Drug and Cosmetic Act. "
In addition," we continue to be concerned about the number of claims for medicines claimed by non-FDA approved products claiming to contain CBD or other cannabis-derived compounds, "said Gottlieb in the statement. [1
The FDA plans to conduct hearings on the opportunities and risks associated with cannabis products.
Aurrora Cannabis is a holding of the Stocks Under $ 10 Portfolio. To learn more, click here.